Leading the Way in Flash Proton Therapy Research
Dedicated research gantry, multidisciplinary collaborations expand the possibilities for curing relapsed and high-risk cancers.
Learn more
New Leaders, New Faculty Members Strengthen Brain Tumor Center
Peter de Blank, MD, MSCE, and Trent Hummel, MD, have been named co-medical directors of the center, which recently welcomed three new neuro-oncologists to the team.
Learn more
First-of-its-Kind Immunotherapy Unit Set to Open This Fall
A unique hybrid model of care will bring together oncology, bone marrow transplant and immunotherapy experts to provide cutting-edge therapies for patients with relapsed and high-risk cancers.
Learn more